Renaissance Technologies’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.68M Buy
828,321
+24,852
+3% +$50.5K ﹤0.01% 2225
2025
Q1
$1.5M Buy
803,469
+63,271
+9% +$118K ﹤0.01% 2164
2024
Q4
$2M Buy
740,198
+94,191
+15% +$254K ﹤0.01% 2055
2024
Q3
$2.44M Sell
646,007
-6,072
-0.9% -$23K ﹤0.01% 1888
2024
Q2
$2.6M Buy
652,079
+136,300
+26% +$544K ﹤0.01% 1707
2024
Q1
$1.53M Buy
515,779
+98,200
+24% +$291K ﹤0.01% 2206
2023
Q4
$2.09M Sell
417,579
-7,600
-2% -$38K ﹤0.01% 1922
2023
Q3
$1.21M Buy
425,179
+7,200
+2% +$20.5K ﹤0.01% 2168
2023
Q2
$1.24M Buy
417,979
+6,900
+2% +$20.4K ﹤0.01% 2335
2023
Q1
$962K Buy
411,079
+6,400
+2% +$15K ﹤0.01% 2507
2022
Q4
$826K Sell
404,679
-30,200
-7% -$61.6K ﹤0.01% 2645
2022
Q3
$1.37M Sell
434,879
-39,711
-8% -$125K ﹤0.01% 2292
2022
Q2
$1.71M Buy
474,590
+22,100
+5% +$79.8K ﹤0.01% 2308
2022
Q1
$1.81M Buy
452,490
+10,300
+2% +$41.2K ﹤0.01% 2302
2021
Q4
$2.19M Buy
442,190
+17,500
+4% +$86.6K ﹤0.01% 2067
2021
Q3
$2.85M Sell
424,690
-1,500
-0.4% -$10.1K ﹤0.01% 1824
2021
Q2
$3.38M Sell
426,190
-100
-0% -$793 ﹤0.01% 1890
2021
Q1
$3.24M Sell
426,290
-152,270
-26% -$1.16M ﹤0.01% 1917
2020
Q4
$2.99M Sell
578,560
-71,651
-11% -$370K ﹤0.01% 1897
2020
Q3
$3.17M Sell
650,211
-135,800
-17% -$663K ﹤0.01% 1851
2020
Q2
$5.29M Buy
786,011
+108,700
+16% +$732K ﹤0.01% 1615
2020
Q1
$4.68M Buy
677,311
+189,909
+39% +$1.31M ﹤0.01% 1609
2019
Q4
$4.15M Buy
487,402
+107,300
+28% +$914K ﹤0.01% 1969
2019
Q3
$1.88M Buy
380,102
+132,063
+53% +$654K ﹤0.01% 2311
2019
Q2
$1.38M Buy
248,039
+27,789
+13% +$154K ﹤0.01% 2543
2019
Q1
$1.11M Buy
220,250
+150,350
+215% +$759K ﹤0.01% 2622
2018
Q4
$661K Buy
69,900
+17,600
+34% +$166K ﹤0.01% 2754
2018
Q3
$418K Buy
52,300
+29,720
+132% +$238K ﹤0.01% 2909
2018
Q2
$210K Sell
22,580
-56,945
-72% -$530K ﹤0.01% 3064
2018
Q1
$822K Buy
79,525
+68,325
+610% +$706K ﹤0.01% 2733
2017
Q4
$143K Buy
+11,200
New +$143K ﹤0.01% 3181
2017
Q3
Sell
-20,100
Closed -$177K 3172
2017
Q2
$177K Buy
+20,100
New +$177K ﹤0.01% 3020